Clinical Trial

RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test the hypothesis that re-treatment of the duodenal mucosa with RF vapor ablation will result in improvement in glycemic parameters, without complications (bleeding/ stricture / perforation) among subjects who failed to show improvement after initial treatment of the duodenal mucosa with RF vapor ablation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-05.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-11-05
Trial Details
NCT Number NCT06724822
Lead Sponsor Aqua Medical, Inc.
Conditions Diabetes Mellitus, Type 2
Enrollment 12 participants
Start Date 2024-11-14
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-06